Author

Melica Nourmoussavi Brodeur

Memorial Sloan Kettering Cancer CenterORCID 0000-0002-7595-0313Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Ana Leda F. LonghiniiD· 1 shared Andrea M. GazzoiD· 1 shared Benjamin D. GreenbaumiD· 1 shared Britta WeigeltiD· 1 shared Dmitriy ZamariniD· 1 shared Elisa de StanchinaiD· 1 shared Higinio DopesoiD· 1 shared Hunter GreeniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ana Leda F. LonghiniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyScience AdvancesPeer-reviewedDec 4, 2024

Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity

Melica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu…·Dmitriy Zamarin

This study shows that SMARCA4 mutations in ovarian cancer increase immunogenicity through interferon response and epigenetic changes, enhancing T cell and NK cell activity in the tumor microenvironment.

26 citations

mousebulk RNA-seq

𝕏 PostBluesky